The laboratory for Neurobiology and gene therapy, headed by Prof. Baekelandt focuses on preclinical Parkinson’s Disease research and has played a pioneering role in recent ground-breaking research, demonstrating a prion-like behaviour of the α-synuclein protein. The group makes use of viral vector technology and molecular imaging as core technologies and is considered a world expert for the application of viral vectors in rodent brain to model and study Parkinson’s disease.
ProjectThe Baekelandt lab together with reMYND (www.remynd.com), will submit a Baekeland PhD project (Vlaio) based on the development and validation of Parkinson’s disease models for drug discovery, both in vitro and in vivo. We are currently looking for a motivated PhD student to embark on a 4-year PhD project. The candidate will be involved in the project writing process and is expected to defend the project for the Vlaio review board. The successful candidate will execute and coordinate in vivo experiments in rodents and studies in primary neurons and other cell cultures. Profile
Offer
Interested?For more information please contact Prof. dr. Veerle Baekelandt, tel.: +32 16 37 40 57, mail: veerle.baekelandt@kuleuven.be or Mrs. Veronique Daniëls, tel.: +32 16 32 63 65, mail: veronique.daniels@kuleuven.be. You can apply for this job no later than July 25, 2020 via the
KU Leuven seeks to foster an environment where all talents can flourish, regardless of gender, age, cultural background, nationality or impairments. If you have any questions relating to accessibility or support, please contact us at diversiteit.HR@kuleuven.be.
|